US Patent Issued on Nov. 11 for "Botulinum toxin formulations and methods for intranasal delivery thereof for the treatment of allergic rhinitis" (Australian Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,563, issued on Nov. 11.

"Botulinum toxin formulations and methods for intranasal delivery thereof for the treatment of allergic rhinitis" was invented by Francesco Barbagallo (Hawthorn, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for intranasal delivery of a formulation comprising Botulinum toxin for the treatment of allergic rhinitis involved impregnating an absorbent tip of an applicator with the formulation, the applicator having a rigid rod having the absorbent tip at a distal end thereof, and inserting the applicator straight into a nasal cavity of a patient beneath the lower turbinates to target the nasal- or nasopharynx-...